Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth …

J Hutton, C McGrath, JM Frybourg… - International journal of …, 2006 - cambridge.org
Objectives: Australia, Canada, and many European countries now use various forms of health
technology assessment (HTA) in decision making regarding the reimbursement of drugs …

The effects of age on spatial frequency perception in human subjects

C McGrath, JD Morrison - Quarterly Journal of Experimental …, 1981 - Wiley Online Library
Visual performance was measured in sixty‐six subjects aged from 5 to 94 years. The curve of
contrast sensitivity against spatial frequency was obtained for each subject. This curve had …

A dynamic perspective on pharmaceutical competition, drug development and cost effectiveness

RR Camejo, C McGrath, R Herings - Health Policy, 2011 - Elsevier
… Rodrigo Refoios Camejo and Clare McGrath are employees of Pfizer but ideas expressed
in this paper are entirely those of the authors and do not necessarily represent the views of …

Diabetic foot care: assessing the impact of care on the whole patient

M Sutton, C McGrath, L Brady… - Practical Diabetes …, 2000 - Wiley Online Library
There is little doubt that provision of special care for people with diabetic foot ulcers reduces
morbidity and amputation. Global efforts have been made to improve care for those who …

A COMPARISON OF PHARMACEUTICAL REIMBURSEMENT AGENCIES'PROCESSES AND METHODS IN FRANCE AND SCOTLAND

M Bending, J Hutton, C McGrath - International Journal of …, 2012 - cambridge.org
Objectives: Pharmaceutical reimbursement agencies’ processes and methods of appraisal
vary across countries. The objective of this study was to examine the contribution of formal …

[HTML][HTML] Using qualitative methods to inform the trade-off between content validity and consistency in utility assessment: the example of type 2 diabetes and …

C Mcgrath, D Rofail, E Gargon, L Abetz - Health and quality of life …, 2010 - Springer
Background Key stakeholders regard generic utility instruments as suitable tools to inform
health technology assessment decision-making regarding allocation of resources across …

Understanding variations in relative effectiveness: A health production approach

A Towse, B Jonsson, C McGrath, A Mason… - International journal of …, 2015 - cambridge.org
Background: Relative effectiveness has become a key concern of health policy. In Europe,
this is because of the need for early information to guide reimbursement and funding …

A systematic review of methodologies, endpoints, and outcome measures in randomized trials of radiation therapy-induced nausea and vomiting

K Dennis, R Jamani, C McGrath, L Makhani… - Supportive Care in …, 2017 - Springer
Purpose Clinical trials in radiation therapy-induced nausea and vomiting (RINV) appear to
have varied methodologies, endpoints, and outcome measures. This complicates trial …

[HTML][HTML] Antihypertensive drugs: a perspective on pharmaceutical price erosion and its impact on cost-effectiveness

RR Camejo, C McGrath, R Herings, WJ Meerding… - Value in Health, 2012 - Elsevier
… Source of financial support: Rodrigo Refoios Camejo and Clare McGrath are employees
of Pfizer but ideas expressed in this article are entirely those of the authors and do not …

[HTML][HTML] Malignant gastric outlet obstruction from pancreatic cancer

C McGrath, A Tsang, H Nithianandan… - Case reports in …, 2018 - karger.com
Patients with advanced-stage pancreatic cancer are typically burdened by many symptoms
that impair functioning and worsen quality of life. We report an exceptional case of a 73-year-…